Institutional investors control 47.13% of the outstanding shares in PTN. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended December 2012, these large investors purchased a net $116.3 thousand shares.
| Other institutional | 46.44% |
| Individual stakeholders | 18.25% |
| Mutual fund holders | 0.69% |